DARZALEX 400MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: JOHNSON & JOHNSON (ONCOLOGY DIV)

MRP: ₹64018.75

JOHNSON & JOHNSON (ONCOLOGY DIV): Darzalex 400MG Injection, 1 vial, salt daratumumab 400mg. Its MRP stays at Rs 64,018.75 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 48,776.19. Group: anti-CD38 monoclonal antibody (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: blood bank must be told before transfusions (it interferes with cross-matching); store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.